In our first pathology update of the Manchester Scoring system, 11% of familial breast cancers that tested negative for BRCA1/2 were lobular, but lobular cancer was present in only 1.6% of index BRCA1 cases [8]. This evidence concerns the gene BRCA1 and breast carcinoma.